These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4167790)

  • 21. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EEG changes in uraemic patients undergoing regular haemodialysis.
    Lavy S; Aviram A
    Electroencephalogr Clin Neurophysiol; 1969 Aug; 27(2):217. PubMed ID: 4184185
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis.
    Segall L; Covic A
    Nephrol Dial Transplant; 2007 Jan; 22(1):59-63. PubMed ID: 17099221
    [No Abstract]   [Full Text] [Related]  

  • 25. Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis.
    Macdonald JA; McDonald SP; Hawley CM; Rosman J; Brown F; Wiggins KJ; Bannister K; Johnson DW
    Nephrol Dial Transplant; 2009 Sep; 24(9):2825-31. PubMed ID: 19443649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transfer from chronic haemodialysis to peritoneal dialysis].
    Lobbedez T; Crand A; Le Roy F; Landru I; Quéré C; Ryckelynck JP
    Nephrol Ther; 2005 Mar; 1(1):38-43. PubMed ID: 16895666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of sodium nitroprusside added peritoneal dialysis and standard haemodialysis.
    Nand N; Mahajan SK; Wig N; Sharma M; Aggarwal HK; Seth RK
    J Assoc Physicians India; 1996 Nov; 44(11):780-3. PubMed ID: 9251452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal dialysis in the management of hypertensive acute oliguric renal failure.
    Ojogwu LI
    Trop Geogr Med; 1983 Dec; 35(4):385-8. PubMed ID: 6670124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in nerve conduction velocity in normal and chronic uraemic patients.
    Jajoo UN; Taori GM; Chaubey BS
    J Assoc Physicians India; 1982 Feb; 30(2):93-6. PubMed ID: 7169417
    [No Abstract]   [Full Text] [Related]  

  • 31. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative losses of free amino acids and their plasma variations in artificial substitutive programmes for chronic uraemia.
    Scolari MP; Stefoni S; Mosconi G; Feliciangeli G; Colì L; Bonomini V
    Life Support Syst; 1983; 1(1):51-60. PubMed ID: 6678371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal dialysis and haemodialysis: are they comparable?
    Prichard SS
    Nephrol Dial Transplant; 1997; 12 Suppl 1():65-7. PubMed ID: 9075232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
    Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
    Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dialysis treatment of chronic renal failure].
    Thieler H
    Zentralbl Chir; 1993; 118(3):118-21. PubMed ID: 8484283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Active treatment of uremia in the study county of Vejle. Epidemiology 1979-1994 and future perspectives].
    Vestergaard P; Frøland A; Kristiansen JH
    Ugeskr Laeger; 1996 Jun; 158(26):3759-63. PubMed ID: 8686069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological manifestations of uraemia and chronic dialysis.
    Tzamaloukas AH; Agaba EI
    Niger J Med; 2004; 13(2):98-105. PubMed ID: 15293824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rethinking the peritoneal dialysis prescription: results of recent studies.
    Bargman JM
    Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EEG in uraemic patients with neuropathy.
    Luijten JA; van Leeuwen WS; Jennekens FG
    Electroencephalogr Clin Neurophysiol; 1970 Apr; 28(4):425. PubMed ID: 4191221
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of haemodialysis on insulin requirements in uraemic diabetic patients. Studies with the artificial beta-cell.
    Schmitz O
    Proc Eur Dial Transplant Assoc; 1983; 19():769-72. PubMed ID: 6348766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.